SCHEMBL21048004

SCHEMBL21048004

CN(CC(F)(F)F)[C@H]1CC[C@H](N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21048003 1.00
SCHEMBL4117080 0.89 PIK3CD (0.31)
Hydrochloric Acid SCHEMBL15847474 0.87 CD38 (0.31)
SCHEMBL12385859 0.81
SCHEMBL12065407 0.78 HRH3 (0.41)
SCHEMBL22351904 0.78 LIPA (0.36)
SCHEMBL12384722 0.78 LIPA (0.36)
SCHEMBL24449570 0.76 THRA (0.33)
SCHEMBL25933141 0.76
SCHEMBL17284202 0.76 MCHR1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479818-B2 Treatment of fibrosis with IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2025-11-25 US disclosed
EP-3707126-B1 IRE1 SMALL MOLECULE INHIBITORS UNIV CORNELL (US) 2025-05-14 EP disclosed
US-20250019369-A1 N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 inhibitors Cerevance, Inc. (US) 2025-01-16 US disclosed
US-20240425477-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2024-12-26 US disclosed
EP-4430034-A1 N-(4-AMINOCYCLOHEXYL)PYRIMIDINE-4-CARBOXAMIDE DERIVATIVES AS CD38 INHIBITORS Cerevance, Inc. (US) 2024-09-18 EP disclosed
US-12071424-B2 IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2024-08-27 US disclosed
US-20230271935-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2023-08-31 US disclosed
US-20230271935-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2023-08-31 US disclosed
US-20230271935-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2023-08-31 US disclosed
WO-2023084206-A1 N-(4-AMINOCYCLOHEXYL)PYRIMIDINE-4-CARBOXAMIDE DERIVATIVES AS CD38 INHIBITORS CEREVANCE LTD (GB) 2023-05-19 WO disclosed
US-10961218-B2 IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2021-03-30 US disclosed
US-20200392106-A1 IRE1 Small Molecule Inhibitors CORNELL UNIVERSITY 2020-12-17 US disclosed
US-20200392106-A1 IRE1 Small Molecule Inhibitors CORNELL UNIVERSITY 2020-12-17 US disclosed
WO-2020232403-A1 TREATMENT OF FIBROSIS WITH IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY (US) 2020-11-19 WO disclosed
WO-2020232401-A1 COMBINATION THERAPIES WITH IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY (US) 2020-11-19 WO disclosed
CN-111566089-A IRE1 small molecule inhibitor 康奈尔大学 2020-08-21 CN disclosed
US-10745379-B2 IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2020-08-18 US disclosed
US-10745379-B2 IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2020-08-18 US disclosed
US-20190169160-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2019-06-06 US disclosed
US-20190169160-A1 IRE1 SMALL MOLECULE INHIBITORS CORNELL UNIVERSITY 2019-06-06 US disclosed